Futurity · Health

Genetic Differences May Explain Endometriosis Pain Variability

New research from Yale School of Medicine may shed light on why some individuals with endometriosis experience severe pain while others remain asymptomatic, regardless of disease extent.

Endometriosis, a condition where uterine-like tissue grows outside the uterus, presents a puzzle as symptom severity doesn't correlate with the amount of disease. Researchers analyzed biopsies from symptomatic and asymptomatic patients to understand pain at a molecular level.

The study, published in Molecular Human Reproduction, identified genetic differences distinguishing painful endometriosis. These findings could lead to new treatments targeting the root causes of pain, rather than just masking symptoms.

Researchers found nearly 900 genes expressed differently between symptomatic and asymptomatic cases, with many related to inflammation. Protein analysis confirmed increased inflammatory molecules in symptomatic patients.

Specifically, elevated levels of the inflammatory cytokine IL16 were linked to pain severity. IL16 may recruit immune cells and promote further inflammation, potentially heightening pain.

Future research will explore IL16 as a drug target, investigating if blocking this protein can reduce endometriosis-related pain. This approach aims to be more effective than current pain management methods.

The study involved analyzing RNA sequencing data from biopsies of nine patients with painful endometriosis and ten asymptomatic patients. Asymptomatic cases were discovered incidentally during surgeries for other conditions.

The researchers emphasize that even minimal endometriosis can cause significant pain, and patient concerns should not be dismissed, as pain severity is not always linked to disease stage.

AI-samenvatting op basis van de bron.